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Abstract 
Objective: Recently, the American Psychiatric Association (DSM-5) and the World 
Health Organization (ICD-11) have both revised their formulation of posttraumatic 
stress disorder (PTSD). The primary aim of this study was to compare DSM-5 and 
ICD-11 PTSD prevalence and comorbidity rates, as well as the level of disability 
associated with each diagnosis. Method: This study was based on a representative 
sample of adult Ukrainian internally displaced persons (IDPs: N = 2,203). PTSD 
prevalence was assessed using the PTSD Checklist for DSM-5 and the International 
Trauma Questionnaire (ICD-11). Anxiety and depression were measured using the 
Generalized Anxiety Disorder Scale and the Patient Health Questionnaire-
Depression. Disability was measured using the WHO Disability Assessment 
Schedule 2.0. 
Results: The prevalence of DSM-5 PTSD (27.4%) was significantly higher than ICD-
11 PTSD (21.0%), and PTSD rates for females were significantly higher using both 
criteria. ICD-11 PTSD was associated with significantly higher levels of disability and 
comorbidity. 
Conclusion: The ICD-11 diagnosis of PTSD appears to be particularly well suited to 
identifying those with clinically relevant levels of disability. 
Key words: Posttraumatic stress disorder (PTSD); DSM-5; ICD-11; Depression; 
Anxiety; Internally displaced persons. 
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Significant Outcomes 
• In a large representative sample of adult Ukrainian IDPs the prevalence of 
DSM-5 PTSD was 27.4% and 21.0% for ICD-11 PTSD. 
• Higher levels of comorbidity with anxiety and depression were found for those 
who met the criteria for ICD-11 PTSD. 
• Higher levels of disability were found for those who met the criteria for ICD-11 
PTSD. 
 
Limitations 
• Self-reported, rather than clinician assessed, PTSD symptoms were used. 
• Disability, as measured using the WHODAS 2.0, was assessed only for the 
previous 30 days. 
• The findings may not generalize to IDP populations in culturally distinct 
contexts. 
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A Comparison of DSM-5 and ICD-11 PTSD Prevalence, Comorbidity, and Disability: 
An Analysis of the Ukrainian Internally Displaced Person’s Mental Health Survey 
The United Nations High Commissioner for Refugees (UNHCR) reported that 
by the end of 2016, 65.6 million people worldwide were forcibly displaced due to 
conflict, violence, or human rights violations1; a record high figure. Of these people, 
40.3 million were forcibly displaced within their own country meaning that internally 
displaced people (IDPs) constitute approximately two-thirds of all displaced people 
worldwide. In Ukraine, specifically, there are currently 1.8 million IDPs, equating to a 
rate of 100 per 1,000 of the population1. IDPs are commonly exposed to multiple 
traumatic life events including war, sexual and physical violence, torture, and 
witnessing death and extreme human suffering1. Recognising the immensely 
deleterious mental health effects of forced displacement for such a large proportion 
of the world’s population, the World Bank and the World Health Organization (WHO) 
recently issued a joint call for the prioritization of mental health as a key component 
of the global health agenda2.    
The American Psychiatric Association (APA)3 and the WHO4 have recently 
revised their formulation of posttraumatic stress disorder (PTSD); a psychiatric 
disorder commonly observed in forcibly displaced people5. The fifth edition of the 
APA’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) includes 20 
symptoms of PTSD that are organised under four symptom clusters; intrusions, 
avoidance, negative alternations in cognitions and mood (NACM), and alternations in 
arousal and reactivity (AR). A diagnosis of PTSD requires exposure to a Criterion 
A stressor and the endorsement of at least one intrusion symptom, one avoidance 
symptom, two NACM symptoms, and two AR symptoms. Additionally, these 
symptoms must be associated with functional impairment, and be present for more 
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than one month. The proposed model of PTSD set forth for the 11th version of the 
International Classification of Diseases (ICD-11) published by the WHO includes six 
symptoms organised under three symptom clusters; re-experiencing of the traumatic 
event(s) in the here and now (Re), avoidance of traumatic reminders (Av), and a 
sense of current threat (Th). A diagnosis of PTSD requires exposure to an extreme 
stressor and the endorsement of at least one symptom from each cluster. 
Additionally, symptoms must be associated with functional impairment, and be 
present for several weeks.  
The ICD-11 proposals for a reduced set of PTSD symptoms were based on 
the desire to (1) simplify the assessment of PTSD to enhance clinical utility, 
particularly in low-resourced and/or humanitarian crisis contexts, (2) reduce the high 
level of symptom profile heterogeneity, and (3) reduce the co-morbidity with other 
disorders4. The simplification of assessment and diagnosis is clearly achieved with a 
much-reduced symptom set. Galatzer-Levy and Bryant5 showed that for DSM-5 
PTSD there are 636,120 different possible symptom combinations for a diagnosis. 
Applying the same methods to ICD-11 PTSD, there are only 27 possible symptom 
combinations for a diagnosis. Whether the ICD-11 model of PTSD reduces 
comorbidity with other disorders is unclear due to the limited number of studies. 
O’Donnell et al.6 reported that in a sample of 953 injury patients, DSM-5 PTSD was 
associated with an 11% higher comorbidity rate with depression as compared to 
ICD-11, although this difference was not statistically significant. Hafstad et al.7 
reported that for parents of young survivors of the 2011 Norway attacks (n = 451), 
ICD-11 PTSD was associated with higher levels of anxiety and depression 
comorbidity compared to DSM-5 PTSD, but this difference was not significant.  
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Studies that have examined differences in prevalence rates between the two 
diagnostic criteria have been somewhat mixed. Significantly higher rates of DSM-5 
PTSD have been reported amongst physical injury patients in Australia6, adult 
survivors of childhood sexual abuse in Denmark8, community and veteran samples 
in the United States9, motor vehicle and incest survivors in Denmark10, and 
treatment-seeking patients in Scotland11. In contrast, Stein et al.12 found no 
difference between DSM-5 and ICD-11 PTSD based on pooled cross-national data 
from 23,936 community participants. Likewise, Hansen et al.10 reported no significant 
differences in PTSD prevalence in five Danish samples (bereaved parents, 
paraplegics, physical assault victims, sexual assault victims, and help-seeking 
trauma patients).  
The main limitation of existing research comparing DSM-5 and ICD-11 PTSD 
prevalence and comorbidity is that, with the exception of one study11, a standardised 
and validated measure of ICD-11 PTSD has not been utilized. To date, ICD-11 
PTSD has generally been assessed using a subset of symptom indicators originally 
developed to measure DSM-based symptoms (DSM-IV or DSM-5). Given that the 
specific symptom content of ICD-11 PTSD does not correspond precisely to the 
DSM-based symptoms, the existing estimates of prevalence and comorbidity across 
the two criteria may be misleading. A disorder-specific measure of ICD-11 PTSD 
(and Complex PTSD), the International Trauma Questionnaire (ITQ)13, was recently 
developed and validated14,15. It is important that any assessment of prevalence rates 
and comorbidity of ICD-11 PTSD be based on an instrument that accurately 
measures the ICD-11 PTSD symptom content, and therefore acknowledges the 
important differences between the ICD-11 and DSM-5 symptom criteria. In particular, 
the ICD-11 emphasises re-experiencing of the traumatic event ‘in the here and now’ 
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as an essential feature of PTSD; a distinction that is often not captured by proxy-
measures designed for DSM-IV or DSM-5 PTSD. Several studies have suggested 
that differences between DSM-5 and ICD-11 PTSD diagnostic rates are attributable 
to differences in the proportion of individuals meeting this criterion7,8. Another 
limitation of the extant research is the use of non-representative, opportunistic 
samples; to date there has been no evaluation of ICD-11 and DSM-5 prevalence and 
co-morbidity rates based on large probability-based samples; or amongst IDPs. 
The primary aim of this study was to compare ICD-11 (using the ITQ) and 
DSM-5 (using the PCL-5) PTSD prevalence and comorbidity rates, in a large, 
representative sample of Ukrainian adult IDPs. On the basis that (a) the current 
study is the first to assess prevalence and comorbidity rates amongst an IDP 
sample; (b) the scant evidence regarding comorbidity across the two criteria; and (c) 
the inconsistent findings regarding prevalence estimates of DSM-5 versus ICD-11 
PTSD, no formal hypotheses were formulated. Rather, we investigated four study 
aims:  
1. To determine the prevalence rates, and gender differences, of DSM-5 and 
ICD-11 PTSD amongst a representative sample of adult Ukrainian IDPs. 
Additionally, we sought to identity individual’s that represented ‘unique’ 
cases of DSM-5 PTSD (i.e., those that meet the diagnostic criteria for 
DSM-5 but not ICD-11 PTSD) and ‘unique’ cases of ICD-11 PTSD (i.e., 
those that meet the diagnostic criteria for ICD-11 but not DSM-5 PTSD).   
2. To determine if there are differences in levels of disability amongst IDPs 
that meet diagnostic status for DSM-5 and ICD-11 PTSD. Differences in 
levels of disability were also compared across ‘unique’ DSM-5 and ICD-11 
PTSD cases. 
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3. To determine the degree of comorbidity for ICD-11 and DSM-5 PTSD with 
Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), 
and combined GAD and MDD. Comorbidity rates for ‘unique’ ICD-11 and 
DSM-5 PTSD cases were also assessed. 
4. To determine if specific types of trauma are differentially associated with 
ICD-11 and DSM-5 PTSD. The association between specific trauma types 
and a ‘unique’ ICD-11 PTSD diagnosis, as compared to a ‘unique’ DSM-5 
PTSD diagnosis, was also assessed.  
METHODS 
Participants 
Data comes from the “Internally Displaced Person’s Mental Health” survey 
that was carried out from March to May 2016 all over Ukraine excluding occupied 
territories17. The survey covered all oblasts of Ukraine and 74 settlements (mainly 
urban). Time-Location Sampling was chosen as a probabilistic method to recruit 
hard-to-reach and migrant populations17. In total, 121 unique locations were used for 
recruitment during the survey: 33.0% from collective centers, 31.0% from NGOs that 
work with IDPs, 6.0% from state institutions, 24.0% were recruited with the help of 
another person (informant), and 6.0% were reached by other means. A weighting 
variable was calculated to correct the regional structure of the sample in accordance 
with official statistics and was applied for all analyses.   
The sample (N = 2,198) includes male and female IDPs (91.8% had official 
IDP status with the UNHCR) who live both in institutional and non-institutional 
settings on the territories controlled by the Ukrainian government. Following agreed 
definitions for IDPs18, a person in the current study was considered an IDP if they 
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answered ‘yes’ to the screening question that they had been forced to flee their 
home because of conflict and were currently living away from their home. Exclusion 
criteria included people deemed under the influence of alcohol or drugs, and those 
with severe intellectual or mental impairment, at the time of the survey. Data 
collectors were trained in the identification of these predetermined exclusion criteria 
which related to criteria of understanding, expression, communication, and 
behaviour. The mean time since displacement was 17.49 months (SD = 4.49). The 
sample included 1496 (68.1%) females, and the mean age was 45 years (SD = 
16.99). The majority of participants reported being married or co-habiting (52.7%), 
20.2% were single, 14.3% were divorced, and 12.8% were widowed. Most 
participants had completed higher education (35.9%) or secondary technical 
education (29.5%) with the remaining having lower levels of educational attainment. 
Most participants who were working were in regular paid work (22.4%) with others in 
irregular paid work (9.9%) or self-employed (2.8%); 28.9% were retired due to old 
age or invalidity and 17.9% were unemployed and seeking work. The remaining 
participants (18.1%) were doing voluntary work, students, homemakers, or on 
maternity leave. 
The questionnaires were completed through face-to-face interviews in either 
Ukrainian or Russian by trained enumerators from the Kiev International Institute of 
Sociology (KIIS) in a private space chosen by the respondent. Before administering 
the questionnaire, each respondent listened to the explanations about the aim of the 
survey and terms of participation. In addition, the participant received an information 
sheet and consent form and then gave either written or verbal consent. Ethical 
approval was provided by the KIIS Institutional Review Board. All team leaders of 
regional groups of interviewers were instructed and trained before the survey, and 
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the team leaders provided the training to their teams of experienced data collectors. 
The response rate of IDPs was around 90% in the whole sample.  
Measures 
ICD-11 PTSD 
The ITQ13 is a preliminary stage, self-report measure of ICD-11 PTSD (and 
Complex PTSD) symptomatology. Six items represent the three clusters of PTSD 
(Re, Av, Th) using two items each. An additional three items measure functional 
impairment associated with these symptoms (e.g., impairment in (1) social, (2) 
occupational, and (3) parenting or other important activities). All items are answered 
on a five-point Likert scale anchored by “Not at all” (0) and “Extremely” (4). 
Diagnostic criteria require a score of ≥ 2 (“Moderately”) for at least one symptom 
from each cluster, along with endorsement of at least one functional impairment 
item. Amongst the current IDP sample the reliability of the total scale (α = .89) and 
the Re (α = .86), Av (α = .75), and Th (α = .81) subscales were good. 
DSM-5 PTSD 
The PCL-519 is a 20-item, self-report measure capturing each DSM-5 PTSD 
symptom. Participants respond using the same 5-point Likert scale as the ITQ. 
Diagnostic criteria require a score of ≥ 2 ("Moderately") for at least one intrusion 
symptom, one avoidance symptom, two NACM symptoms, and two arousal 
symptoms. Endorsement of at least one functional impairment item is also required 
(the PCL-5 and ITQ use the same functional impairment items). The PCL-5 has 
demonstrated acceptable reliability and validity in previous studies20. Amongst the 
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current sample, the reliability of the total scale (α = .96) and the intrusions (α = .89), 
avoidance (α = .88), NACM (α = .90), and AR (α = .89) subscales were good.  
Lifetime Traumatic Exposure 
The Life Events Checklist (LEC)21 is a 17-item, self-report measure screening 
for lifetime traumatic exposures. The LEC assesses lifetime exposure to 16 traumas 
plus one open question for respondents to indicate any other traumatic event not 
listed. The overwhelming majority of respondents indicated exposure to at least one 
traumatic life event (93.3%, n = 2051) and the most commonly reported trauma was 
exposure to war or combat (71.3%, n = 1566). For each item, the respondent checks 
whether the event ‘Happened to me’ (1), ‘Witnessed it happening to somebody else’ 
(2), ‘Learned about it happening to someone close to me’ (3), ‘Part of my job’ (4), 
‘Not sure it applies’ (5), ‘Doesn't apply to my experience’ (6). The scores were 
recoded into binary variables with ‘Happened to me’ responses being coded as 1 
and all other responses coded as 0, except for the ‘Sudden violent death’ and 
‘Sudden accidental death’ items which were coded 1 for ‘Witnessed it happening to 
somebody else’ and all other responses coded as 0. 
Measures of Psychiatric Comorbidity 
The Generalized Anxiety Disorder Scale (GAD-7)22 is a 7-item, self-report 
measure assessing each DSM-IV symptom of GAD. The instructions state, “Over the 
last 2 weeks, how often have you been bothered by any of the following problems?” 
and participants respond using a 4-point Likert scale ("Not at all" (0) to "nearly every 
day" (3)). Total scores on the GAD-7 range from 0 to 21. Scores ≥ 10 are used as a 
cut-off to identify diagnosis of GAD23. The reliability of the scale in this sample was 
high (α = .93). 
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The Patient Health Questionnaire-Depression (PHQ-9)24 is a 9-item, self-
report measure assessing each DSM-IV symptom of MDD. Instructions and 
response options are the same as the GAD-7. Total scores range from 0 to 27. 
Scores ≥ 10 are used as a cut-off to identify diagnosis of MDD26. The reliability of the 
scale in this sample was high (α = .91). 
Disability 
The WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)26 is a 12-item 
self-report measure that assesses activity limitations and participation restrictions in 
six domains (Understanding and communicating, Mobility, Self-care, Social 
functioning, Household activities, Community activities). The instructions state, “In 
the last 30 days how much difficulty did you have inQ”, and participants respond to 
each item using a 5-point Likert scale ranging from “None” (0) to “Extreme or cannot 
do” (4). Total scores range from 0 to 48 with higher scores reflecting greater levels of 
disability. No agreed upon cut-off score exists for the WHODAS 2.0, however scores 
≥ 10 have been shown to include the top 10% of the population distribution of 
WHODAS 2.0 scores, and therefore likely to reflect those with clinically relevant 
levels of disability27. Consistent with previous PTSD-based studies7, a score ≥ 10 
was used in the current study to identify individuals with ‘clinically significant levels of 
disability’. The reliability of the scale in this sample was high (α = .94). 
The survey questionnaire was largely developed in English and then 
underwent a thorough adaptation and translation process into Ukrainian and Russian 
based on best practice procedures to help ensure reliability, validity and 
appropriateness with the study population. This included: (i) translation from English 
into Ukrainian and Russian using professional translators, with translations reviewed 
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by mental health experts individually and then as a group for cultural relevance, 
content and concept consistency, clarity, and understanding; (ii) a back-translation to 
check for accuracy, consistency, and equivalence, with adjustments made 
accordingly; and (iii) piloting and field testing a1 to refine the instruments further28. 
Ukrainian and Russian versions of the PCL-5, PHQ-9, and LEC-5 instruments were 
used as they already existed but were still subject to the back-translation and expert 
discussion. 
Analysis 
The prevalence rates were estimated using the weighted frequencies (and 
percentages) with 95% confidence intervals, and group comparisons were 
conducted using the exact McNemar binomial test. Differences in percentages were 
expressed as ‘percentage change’ ((%1 - %2) / (%1) x 100). The reliability of all self-
report scales were assessed using Cronbach’s alpha. The associations between 
trauma exposure and diagnostic status were estimated using binary logistic 
regression. 
RESULTS 
Prevalence Rates 
                                                            
a1
 The piloting was conducted with approximately 30 IDPs in Kiev who were not included in 
the main survey conducted later on. The piloting sought to assess the (1) clarity, 
comprehension, comprehensiveness of the questionnaire, (2) understanding of the consent 
procedures, (3) feasibility (e.g. questionnaire administration time, respondent willingness to 
participate), (4) potential for respondent burden and distress, (5) socio-cultural 
appropriateness, and (6) formatting of the questionnaire (e.g. skip patterns, ordering of the 
questions). Any key findings were noted by data collectors. They also asked participants 
about the survey instrument and any comments they had on it (based on the criteria noted 
above). The findings were then shared with the management team and discussed and 
alterations made where appropriate.   
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The prevalence of DSM-5 PTSD was 27.4% (95% CI = 25.52 – 29.33%), 
while the prevalence of ICD-11 PTSD was 21.0% (95% CI = 19.18 – 22.65%); 
representing an increase of 30.5% in diagnostic rates under DSM-5 (see Table 1). 
This difference in diagnostic rates according to the two criteria was statistically 
significant (exact binomial test: p < .001). There were a larger number of ‘unique’ 
DSM-5 PTSD cases (9.6%, n = 197) than ‘unique’ ICD-11 PTSD cases (3.5%, n = 
71). Additionally, 17.6% (n = 362) of IDPs met the diagnostic criteria for both DSM-5 
and ICD-11 PTSD; a level of diagnostic agreement that was considered to be 
‘substantial’ 30 (k = .64, SE = .02, p < .001). 
DSM-5 PTSD rates were significantly higher for females (31.1%; 95% CI = 
29.05 – 33.92%) than males (19.6%; 95% CI = 16.29 – 22.33%) representing an 
increase of 58.1%. ICD-11 PTSD rates were also significantly higher for females 
(24.6%; 95% CI = 22.57 – 27.11%) than males (13.1%; 95% CI = 10.46 – 15.61%) 
representing an increase of 87.8% (see Table 1).  
Table 1 here 
 The difference in PTSD prevalence across the two diagnostic systems is 
primarily due to variation in the proportion of IDPs that meet the respective 
‘Intrusions’ (DSM-5: 71.5%) and ‘Re-experiencing’ (ICD-11: 31.9%) symptom criteria. 
The proportion of individuals meeting criteria for Avoidance (DSM-5 = 54.1%, ICD-11 
= 51.0%), and Arousal (DSM-5: 39.1%) and Sense of Threat (ICD-11: 40.2%) were 
concordant.   
Disability and Comorbidity Rates 
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Amongst those with a DSM-5 PTSD diagnosis, 48.5% experienced clinically 
significant levels of disability, and 57.6% of those with an ICD-11 PTSD diagnosis 
experienced clinically significant levels of disability. ‘Unique’ ICD-11 PTSD was 
associated with significantly higher levels of disability compared to ‘unique’ DSM-5 
PTSD (36.7% v. 28.6%, exact binomial test: p < .001). 
Based on the GAD-7, 16.1% of participants met the criteria for GAD, and 
based on the PHQ-9, 20.6% of the participants met the criteria for MDD; 10.8% met 
the criteria for both GAD and MDD. The rates of comorbidity of PTSD with GAD, 
MDD, and combined GAD and MDD, respectively, were all higher for ICD-11 PTSD 
than DSM-5 PTSD. For ‘unique’ cases of PTSD, comorbidity rates with GAD, and 
combined GAD and MDD, were significantly higher for ICD-11 PTSD, whereas 
comorbidity with MDD was significantly higher for DSM-5 PTSD (Table 2). 
Table 2 here 
PTSD and Traumatic Exposure 
A series of bivariate binary logistic regression models were tested. Each 
trauma from the LEC was used as a predictor variable and the ICD-11 and DSM-5 
diagnoses were used as criterion variables (see Table 3). Most traumatic 
experiences were significantly related to a DSM-5 PTSD diagnosis, except for 
‘exposure to a war-zone’ and ‘captivity’. The largest effects were for ‘serious injury, 
harm, or death you caused to someone else’ (OR = 3.00), ‘sexual assault’ (OR = 
2.95), and ‘life-threatening illness or injury’ (OR = 2.59). Most traumatic experiences 
were also significantly related to ICD-11 PTSD, except for ‘captivity’. The largest 
effects were for ‘sexual assault’ (OR = 3.66), ‘other unwanted or uncomfortable 
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sexual experience’ (OR = 3.28), and ‘serious injury, harm, or death you caused to 
someone else’ (OR = 2.80).  
Finally, a series of bivariate binary logistic regression analyses were 
conducted to determine the association between each trauma from the LEC and a 
‘unique’ ICD-11 PTSD diagnosis (the ‘unique’ DSM-5 PTSD diagnosis group were 
used as the reference category for these analyses). As detailed in Table 3, one 
traumatic event, ‘severe human suffering’, was significantly related to an elevated 
risk of ‘unique’ ICD-11 PTSD (OR = 1.76). Exposure to a ‘transportation accident’ 
was significantly related to a reduced risk of ‘unique’ ICD-11 PTSD (OR = .22).   
Table 3 here 
Discussion 
The primary objective of the current study was to provide the first 
methodologically rigorous assessment of the prevalence and comorbidity rates of 
ICD-11 and DSM-5 PTSD in a large, representative sample of internally displaced 
Ukrainian adults. The first aim of the study was to determine if prevalence rates of 
PTSD varied significantly across the two diagnostic systems and we found that 
DSM-5 was associated with 30.5% more diagnostic cases. Although the reported 
level of kapp (.64) is described as ‘substantial’ according to Cohen’s criteria, it 
represents a level of agreement that is lower than expected for two measures that 
purportedly measure the same construct. More context specific interpretations of 
kappa have been proposed by McHugh30 who suggested that levels of agreement 
over .80 are more appropriate in clinical research. These findings are consistent with 
a number of studies that have reported significantly lower rates of PTSD for ICD-11 
compared to DSM-57,8-11. Furthermore, as in prior studies7,8, the significantly lower 
Page 16 of 31Acta Psychiatrica Scandinavica submitted manuscript
17 
 
rates of ICD-11 PTSD were largely attributable to fewer individuals satisfying the 
newly proposed ‘re-experiencing’ criteria. The stipulation of re-experiencing the 
traumatic event in the here and now for ICD-11 may represent a less common 
psychological reaction as compared to other forms of re-experiencing that are 
included within the DSM-5 (e.g., becoming upset upon reminders of a trauma). The 
focus on present-moment re-experiencing may result in the ICD-11 diagnosis being 
more ‘difficult’ to attain, that is, a person requires a more intense and distressing 
reliving of the trauma before meeting the diagnostic criteria. Another possibility is 
that the broader nature of DSM-5 PTSD, with the inclusion of multiple non-trauma 
specific symptoms, can result in an ‘easier’ PTSD diagnosis. If one considers that 
the psychological response to trauma can be represented as an underlying 
continuum of distress severity, then the threshold for a DSM-5 diagnosis lies lower 
on the continuum than an ICD-11 diagnosis.  
This conclusion is supported by the results of the association between PTSD 
status and disability. A significantly greater number of individuals who met diagnosis 
under ICD-11, compared to DSM-5, exhibited clinically meaningful levels of disability. 
The same pattern of results was also identified when unique cases of ICD-11 and 
DSM-5 PTSD were compared. Although a PTSD diagnosis according to both the 
DSM-5 and the ICD-11 identified a substantial number of people with high levels of 
impairment in daily functioning, it appears that the ICD-11 diagnosis, in particular, is 
sensitive at capturing individuals experiencing clinically significant levels of disability.  
The study’s second aim was to assess whether significant gender differences 
existed in PTSD prevalence for DSM-5 and ICD-11 PTSD. For the ICD-11 diagnosis, 
the rate for females was almost double that for males, and for DSM-5 the increase 
was approximately one third. This is consistent with the plethora of research that has 
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identified significant gender differences31 but the difference in prevalence based on 
the DSM-5 was smaller than the 2:1 ratio that has been reported in population based 
studies31. 
Although PTSD prevalence was common amongst this sample of Ukrainian 
IDPs, irrespective of which diagnostic systems was selected, the level of diagnostic 
agreement between the two systems was quite low. Only 17.6% of IDPs were 
diagnosed with PTSD according to both the ICD-11 and DSM-5 diagnostic 
algorithms. A substantial number of IDPs qualified for a diagnosis of PTSD according 
to the DSM-5 but not the ICD-11 (9.6%), while a smaller number qualified for a 
diagnosis of PTSD according to the ICD-11 but not the DSM-5 (3.5%). This 
demonstrates that there are a considerable number of trauma-survivors who will only 
meet diagnostic status under one of the two available criteria. This circumstance has 
been highlighted as a challenge to the field of psychotraumatology as victims of 
trauma, and their caregivers, may be denied compensation and/or insurance 
coverage depending upon which diagnostic system is selected32. Regrettably, this 
set of affairs is likely to persist into the near future and until there is an agreed-upon 
diagnostic model of PTSD. 
The third aim of this study was to assess the degree of comorbidity for ICD-11 
and DSM-5 PTSD with GAD, MDD, and combined GAD and MDD. The ICD-11 
proposals for a reduced symptom set related to ‘core’ PTSD symptoms were, in part, 
aimed at reducing the high levels of comorbidity that have been reported, particularly 
with other mood and anxiety disorders33. However, contrary to this proposition, 
significantly higher levels of comorbidity with GAD (7.9%), MDD (6.5%) and 
combined GAD and MDD (8.1%) were associated with ICD-11 PTSD, not DSM-5 
PTSD. An interesting pattern of comorbidity emerged when unique ICD-11 and 
Page 18 of 31Acta Psychiatrica Scandinavica submitted manuscript
19 
 
DSM-5 PTSD cases were compared. The unique ICD-11 PTSD cases were 
associated with higher comorbidity rates for GAD and combined GAD and MDD, 
whereas unique cases of DSM-5 PTSD were associated with higher comorbidity 
rates for MDD. These findings suggest that ICD-11 PTSD shares more in common 
with anxiety disorders, while DSM-5 shares more in common with depressive 
disorders. These findings are congruent with theoretical proposals4 and prior 
empirical results6.  
The high levels of comorbidity, and the specific patterns of comorbidity, are 
difficult to interpret within a traditional categorical model of psychopathology where a 
focus on unique symptoms rather than trans-diagnostic symptoms should reduce 
comorbidity. However, these findings do make sense within a dimensional model of 
psychopathology. Recently, Kotov et al.34 proposed the ‘Hierarchical Taxonomy of 
Psychopathology’ (HiTOP) model that is based on an abundance of empirical data 
indicating that psychiatric disorders cluster into meaningful superordinate latent 
factors (e.g., dimensions of ‘Internalising’, ‘Externalising’, and ‘Thought Disorder’)35-
37. The HiTOP model considers diagnoses such as PTSD, GAD, and MDD as 
‘syndromes’ occurring under the ‘Distress’ factor; a sub-factor subsumed by a 
superordinate ‘Internalising’ psychopathology dimension. This hierarchical model 
assumes a causal system similar to the factor analytic or ‘effect’ indicator model38 
which posits downward causal effects. This means that increased levels of 
Internalising psychopathology will increase the likelihood of higher levels of the 
‘Distress’ sub-factor which will consequently result in increased scores in all of its 
‘indicators’ (i.e., syndromes) such PTSD, GAD, and MDD. In other words, under the 
assumption of a dimensional model of psychopathology, high levels of comorbidity 
between PTSD, GAD, and MDD are unavoidable given their shared relationship to 
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an underlying latent variable (Internalizing). Furthermore, as in factor analytic 
models, when ‘indicators’ (e.g., PTSD) are measured with greater precision and less 
error (e.g., by focusing on ‘core symptoms’), the observed covariation with other 
indicators (e.g., GAD, MDD) will inevitably increase. The objective of the revision to 
ICD-11 PTSD to reduce comorbidity with other ‘Internalizing’ disorders through a 
focus on core symptoms may therefore be unachievable given the assumptions 
associated with a categorical model of psychopathology.  
There are two other factors that may help to explain the observed comorbidity 
rates. First, it is likely that exposure to traumatic stressors is an etiological risk factor 
not just for PTSD, but also for many other psychiatric conditions including depression 
and anxiety. As the ICD-11 model of PTSD reflects a more ‘specific’ disorder than 
DSM-5 PTSD, it is important that clinicians screen for other conditions such as GAD 
and MDD amongst trauma-exposed persons when adopting the use of the ICD-11 
model of PTSD. Secondly, the current findings suggest that ICD-11 PTSD also 
represents a more ‘severe’ psychiatric disorder than DSM-5 PTSD. Consequently, 
an increased likelihood of diagnostic comorbidity associated with ICD-11 PTSD may 
be precisely what one should expect to observe.   
  The study’s fourth objective sought to determine if there are specific types of 
trauma that are differentially associated with ICD-11 and DSM-5 PTSD. When 
examining the relative relationships between each trauma type and risk of DSM-5 or 
ICD-11 PTSD, the traumatic events that were more strongly associated with ICD-11 
PTSD included sexual assault, unwanted sexual contact, exposure to war, and 
exposure to severe human suffering; traumatic events that are widely recognised as 
the most distressing/impairing30,39. Furthermore, exposure to severe human suffering 
was found to significantly increase the likelihood of having a ‘unique’ ICD-11 PTSD 
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diagnosis compared to a ‘unique’ DSM-5 PTSD diagnosis, whereas exposure to a 
transportation accident was found to decrease the likelihood of having a ‘unique’ 
ICD-11 PTSD diagnosis. Here again evidence was found to suggest that ICD-11 
PTSD may be associated with increased scores on an underlying distress 
continuum.   
Several limitations associated with the current study should be recognised. 
While the representative nature of the current sample is a key strength, the current 
findings may not generalize to IDP populations in culturally distinct contexts. The use 
of self-report measures to estimate prevalence and comorbidity rates may be 
considered sub-optimal as compared to the use of diagnostic interviews. It is 
possible therefore that estimates of the prevalence and comorbidity may be 
somewhat overestimated. However, for the purposes of the current study where we 
sought to compare DSM-5 and ICD-11 prevalence, and their comorbidity with GAD 
and MDD, this limitation was constant across all analyses meaning that current 
results are interpretable. Finally, it was not possible to assess comorbidity rates with 
disorders reflecting the ‘Externalizing’ and ‘Thought Disorder’ dimensions of 
psychopathology. It’s possible that differences in comorbidity rates for ICD-11 and 
DSM-5 could vary depending upon which disorders are selected. Future research 
should therefore seek to estimate comorbidity with disorders reflecting traditional 
Externalizing psychopathology (e.g., addiction) and Thought Disorder 
psychopathology (e.g., schizophrenia).  
In conclusion, a fundamental goal of the ICD-11 is that diagnoses be cross-
culturally relevant, particularly within low-resourced and/or humanitarian crisis 
situations. The current findings with Ukrainian IDPs provides initial evidence that the 
ICD-11 diagnosis of PTSD is meaningful in such a context. Our findings have 
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important implications for clinicians working with IDPs. The ICD-11 diagnosis of 
PTSD is particularly helpful at detecting individuals experiencing higher levels of 
psychiatric distress and disability, and therefore those in the greatest need of clinical 
intervention. The ICD-11 model may therefore be considered optimal in humanitarian 
contexts where clinical resources are limited. However, clinicians should also be 
aware that the ICD-11 criteria will likely yield fewer diagnostic cases of PTSD 
compared to the DSM-5 criteria and should therefore screen for other psychiatric 
disorders that are common posttrauma. 
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Table 1. Probable PTSD Prevalence based on DSM-5 and ICD-11. 
 
Note: χ2 = chi-square test, df = degrees of freedom, p = level of statistical 
significance. 
 
 
 
  
PTSD diagnosis Male Female Total χ2 (df)  p 
 N = 677 N = 1423 N = 2100  
     
DSM-5 133 (23.1%) 442 (31.1%) 575 (27.4%) 30.07 (1) <.001 
ICD-11 87 (13.1%) 350 (24.6%) 438 (21.0%) 36.30 (1) < .001 
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Table 2. Comorbidity of DSM-5 and ICD-11 PTSD with Generalized Anxiety Disorder  
 
Note: GAD = Generalised Anxiety Disorder; MDD= Major Depressive Disorder; * all 
differences are statistically significant (p < .05). 
PTSD diagnosis % with GAD % with MDD % with GAD and 
MDD 
Comorbidity rates for ICD-11 and DSM-5 PTSD 
ICD-11 54.6% 64.3% 43.2% 
DSM-5 46.7% 57.7% 35.0% 
Difference 7.9%* 6.5%* 8.1%* 
Comorbidity rates for ‘unique’ cases of ICD-11 and DSM-5 PTSD 
Unique ICD-11 29.3% 34.6% 22.8% 
Unique DSM-5 25.5% 36.6% 15.9% 
Difference  3.8%* 2.0%* 6.9%* 
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Table 3. Association Between Trauma Exposure and Probable DSM-5 and ICD-11 PTSD. 
 N (%) exposed DSM-5 PTSD ICD-11 PTSD Unique ICD-11 
PTSDa 
Life Event  OR (95% CI) OR (95% CI) OR (95% CI) 
1. Natural disaster (for example, flood, 
hurricane, tornado, earthquake) 
98 (4.5%) 2.06 (1.36-3.11)* 1.59 (1.01-2.50)* .72 (.25-2.06) 
2. Fire or explosion 637 (29.0%) 1.39 (1.13-1.70)* 1.68 (1.35-2.10)* 1.19 (.66-2.15) 
3. Transportation accident (for example, 
car accident, boat accident, train 
wreck, plane crash) 
204 (9.3%) 1.87 (1.38-2.54)* 1.50 (1.07-2.10)* .22 (.06-.85)* 
4. Serious accident at work, home, or 
during recreational activity 
286 (13.0%) 1.86 (1.43-2.42)* 1.43 (1.07-1.91)* .45 (.19-1.05) 
5. Exposure to toxic substance (for 
example, dangerous chemicals, 
radiation) 
64 (2.9%) 1.82 (1.09-3.06)* 1.21 (.67-2.18) .49 (.11-2.08) 
6. Physical assault (for example, being 
attacked, hit, slapped, kicked, beaten 
up) 
261 (11.9%) 2.38 (1.82-3.12)* 2.04 (1.53-2.73)* .60 (.26-1.38) 
7. Assault with a weapon (for example, 
being shot, stabbed, threatened with a 
knife, gun, bomb) 
272 (12.4%) 1.56 (1.19-2.05)* 1.73 (1.30-2.31)* 1.42 (.67-2.99) 
8. Sexual assault (rape, attempted rape, 
made to perform any type of sexual act 
through force or threat of harm) 
54 (2.5) 2.95 (1.71-5.09)* 3.66 (2.12-6.32)* 1.78 9.43-7.31) 
9. Other unwanted or uncomfortable 
sexual experience 
49 (2.2%) 2.07 (1.15-3.75)* 3.28 (1.82-5.92)* 4.54 (.73-28.25) 
10. Combat or exposure to a war-zone (in 
the military or as a civilian) 
1566 (71.3%) .97 (.79-1.20) 1.28 (1.01-1.63)* 1.36 (.76-2.43) 
11. Captivity (for example, being 
kidnapped, abducted, held hostage, 
prisoner of war) 
43 (2.0%) 1.15 (.59-2.22) 1.30 (.65-2.61) .22 (.00-48.26) 
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Note: OR (95% CI) = Odds ratio with 95% confidence intervals; * = p < .05; a reference group in this case are the ‘unique’ DSM-5 
PTSD cases. 
 
 
 
12. Life-threatening illness or injury 353 (16.1%) 2.59 (2.04-3.30)* 2.49 (1.93-3.21)* .87 (.46-1.67) 
13. Severe human suffering 929 (42.3) 2.22 (1.83-2.70)* 2.69 (2.16-3.34)* 1.76 (1.01-3.08)* 
14. Witnessed sudden violent death (for 
example, homicide, suicide) 
147 (6.7%) 1.75 (1.23-2.47)* 1.54 (1.05-2.26)* .62 (.19-1.97) 
15. Witnessed sudden accidental death 121 (5.5%) 1.61 (1.10-2.36)* 1.59 (1.05-2.40)* .62 (.16-2.38) 
16. Serious injury, harm, or death you 
caused to someone else 
40 (1.8%) 3.00 (1.60-5.62)* 2.80 (1.46-5.38)* 1.19 (.33-4.32) 
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